THE ROLE OF HBOT IN CEREBRAL PALSY
Cerebral Palsy (CP) is a descriptive neurological and physical problem originating from defects in motor cortices. Collectively these are labeled as cerebral palsy.
Cerebral Palsy is non-progressive, non-contagious, permanent neurological abnormality. The location and size of the lesion will determine what deficit the child will have. The abnormalities occur in utero, during or after birth up until age five. The affected individual is influenced by genetic and environmental factors as well. Cerebral Palsy is associated with a perinatal hypoxic event (tight nuchal or prolapsed cord), placental abnormalities , prolonged labor, or infection transmitted during delivery.
There is no known cure for cerebral palsy, and there is no standard therapy. Early treatment gives a child a better chance to overcome disabilities.

Two alternative therapies considered by some to be controversial include neuromuscular electrical stimulation and hyperbaric oxygen therapy (HBOT). HBOT might be beneficial in treating Cerebral Palsy cases that are due to traumatic brain injury caused by decreased oxygen.

The theoretical basis for HBOT in CP is that there are areas in the brain next to the CP lesions that are hypoxic due to marginal tissue perfusion. HBOT can increase the available oxygen to these marginal tissues and reactivate the cells to become functional. The number of cells that can be “salvaged” by HBOT cannot be determined. HBOT might cause improvement in motor skills, attention span, visual and verbal commands.
For this treatment, HBOT is used at “low pressure” (1.5 to 1.7 atmospheres absolute), as this has been demonstrated to be optimal pressure that an injured brain can tolerate without toxicity.